Breast-fed babies, so the prevailing wisdom goes, are less likely to have weight problems later in life. Introducing solid foods later — at about four or six months — is also thought to reduce the risk of being overweight later in childhood.
The Food and Drug Administration approved Eraxis (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems.
The Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression.
Carpal tunnel syndrome (CTS) is a medical condition in which the median nerve is compressed at the wrist causing symptoms like tingling, numbness, night time wakening, pain, coldness, and sometimes weakness in parts of the hand.
The Food and Drug Administration (FDA), the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Medicare & Medicaid Services (CMS) today announced the Oncology Biomarker Qualification Initiative (OBQI) — an agreement to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation.
Alzheimer’s disease, a leading cause of dementia in the elderly, appears later in highly educated people — but once it does, it advances more quickly, scientists said.
The Food and Drug Administration has issued draft guidance on what the term “whole grain” may include. The guidance will assist manufacturers with what the FDA considers appropriate for food label statements related to “whole grain” content. Consumers will now be able to make dietary choices based on a term that is consistent and reliable.
A very commonly seen problem in the clinic for which parents seek treatment and get concerned out of proportion. Children vary in the age at which they gain nocturnal continence of urine. About 10-15% of normal children at the age of 5 years still wet the bed at night. Boys slightly predominate over girls (as girls generally attain nocturnal bladder control early than boys), and there is increased incidence in some families. The factors leading to gaining in the bladder control are complex and involve maturation of the necessary neurological pathways as well as emotional factors.
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) – a project developed by the National Institutes of Health (NIH) – is seeking 800 older adults to participate in a study aimed at identifying biological markers of memory decline and Alzheimer’s disease (AD). Ultimately, scientists hope that brain and biological changes can be detected before memory decline and other symptoms appear, allowing the effectiveness of drugs to be evaluated at the earliest possible time.
Diabetes’ links to gum disease are well-known, but a new study shows it can trigger periodontal problems in children as young as 6.